Intravitreal Combined Aflibercept + Anti-Platelet-Derived Growth Factor Receptor β for Neovascular Age-Related Macular Degeneration: Results of the Phase 2 CAPELLA Trial

To compare the efficacy and safety of intravitreal aflibercept + anti-platelet-derived growth factor receptor β (PDGFRβ) combination with intravitreal aflibercept injection (IAI) monotherapy in patients with treatment-naïve neovascular age-related macular degeneration (nAMD). Phase 2, randomized, do...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Ophthalmology (Rochester, Minn.) Minn.), 2020-02, Vol.127 (2), p.211-220
Hauptverfasser:	Heier, Jeffrey S, Wykoff, Charles C, Waheed, Nadia K, Kitchens, John W, Patel, Sunil S, Vitti, Robert, Perlee, Lorah, Chu, Karen W, Leal, Sergio, Asmus, Friedrich, Son, Vladimir, Schmelter, Thomas, Brown, David M
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!